Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis.

Agzarian J, Litle V, Linkins LA, Brunelli A, Schneider L, Kestenholz P, Li H, Rocco G, Girard P, Nakajima J, Samama CM, Scarci M, Anraku M, Falcoz PE, Bertolaccini L, Lin J, Murthy S, Hofstetter W, Okumura M, Solli P, Minervini F, Kirk A, Douketis J, Shargall Y.

Eur J Cardiothorac Surg. 2019 Nov 26. pii: ezz319. doi: 10.1093/ejcts/ezz319. [Epub ahead of print]

PMID:
31769796
2.

Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey.

Shargall Y, Brunelli A, Murthy S, Schneider L, Minervini F, Bertolaccini L, Agzarian J, Linkins LA, Kestenholz P, Li H, Rocco G, Girard P, Venuta F, Samama M, Scarci M, Anraku M, Falcoz PE, Kirk A, Solli P, Hofstetter W, Okumura M, Douketis J, Litle V.

Eur J Cardiothorac Surg. 2020 Feb 1;57(2):331-337. doi: 10.1093/ejcts/ezz191.

PMID:
31363740
3.

Shelly, MAiD and the purple parade.

Linkins LA.

CMAJ. 2019 Jun 17;191(24):E668-E669. doi: 10.1503/cmaj.190082. No abstract available.

PMID:
31209135
4.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N.

Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489.

5.

Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials.

Linkins LA, Hu G, Warkentin TE.

Res Pract Thromb Haemost. 2018 Aug 9;2(4):678-683. doi: 10.1002/rth2.12145. eCollection 2018 Oct.

6.

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT.

Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I.

Blood. 2018 Sep 20;132(12):1345-1349. doi: 10.1182/blood-2018-04-847483. Epub 2018 Jul 31. No abstract available.

7.

Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study.

Serrano PE, Parpia S, Linkins LA, Elit L, Simunovic M, Ruo L, Bhandari M, Levine M.

Ann Surg Oncol. 2018 Oct;25(11):3214-3221. doi: 10.1245/s10434-018-6671-7. Epub 2018 Jul 26.

PMID:
30051364
8.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: reply.

Takach Lapner S, Julian JA, Linkins LA, Bates SM, Kearon C.

J Thromb Haemost. 2018 Jul;16(7):1448-1450. doi: 10.1111/jth.14155. Epub 2018 Jun 12. No abstract available.

PMID:
29771476
9.

Management of cancer-associated upper extremity deep vein thrombosis with and without venous catheters at a tertiary care center.

ALKindi SY, Chai-Adisaksopha C, Cheah M, Linkins LA.

Thromb Res. 2018 Jun;166:92-95. doi: 10.1016/j.thromres.2018.03.020. Epub 2018 Apr 3.

PMID:
29704767
10.

Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma.

Mian H, Warkentin TE, Sheppard JI, MacDonald A, Linkins LA, Benger A, Foley R.

Blood. 2017 Oct 5;130(14):1679-1682. doi: 10.1182/blood-2017-06-788679. Epub 2017 Aug 22. No abstract available.

PMID:
28830891
11.

Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism.

Takach Lapner S, Julian JA, Linkins LA, Bates S, Kearon C.

Thromb Haemost. 2017 Oct 5;117(10):1937-1943. doi: 10.1160/TH17-03-0182. Epub 2017 Aug 3.

PMID:
28771280
12.

Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.

Warkentin TE, Pai M, Linkins LA.

Blood. 2017 Aug 31;130(9):1104-1113. doi: 10.1182/blood-2017-04-778993. Epub 2017 Jun 23. Review.

PMID:
28646118
13.

Review of D-dimer testing: Good, Bad, and Ugly.

Linkins LA, Takach Lapner S.

Int J Lab Hematol. 2017 May;39 Suppl 1:98-103. doi: 10.1111/ijlh.12665. Review.

PMID:
28447414
14.

Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I.

Thromb Res. 2017 May;153:108-117. doi: 10.1016/j.thromres.2017.03.010. Epub 2017 Mar 11.

15.

Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey.

Agzarian J, Linkins LA, Schneider L, Hanna WC, Finley CJ, Schieman C, De Perrot M, Crowther M, Douketis J, Shargall Y.

J Thorac Dis. 2017 Jan;9(1):80-87. doi: 10.21037/jtd.2017.01.38.

16.

Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.

Chai-Adisaksopha C, Linkins LA, ALKindi SY, Cheah M, Crowther MA, Iorio A.

Thromb Haemost. 2017 Feb 28;117(3):589-594. doi: 10.1160/TH16-09-0680. Epub 2017 Jan 12.

PMID:
28078351
17.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies.

Takach Lapner S, Julian JA, Linkins LA, Bates SM, Kearon C.

J Thromb Haemost. 2016 Oct;14(10):1953-1959. doi: 10.1111/jth.13424. Epub 2016 Aug 31.

18.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: reply.

Takach Lapner S, Julian JA, Linkins LA, Bates S, Kearon C.

J Thromb Haemost. 2016 Dec;14(12):2555-2556. doi: 10.1111/jth.13512. Epub 2016 Oct 20. No abstract available.

19.

End of the road for heparin thromboprophylaxis.

Linkins LA.

Blood. 2016 Apr 21;127(16):1945-6. doi: 10.1182/blood-2016-02-697144. No abstract available.

PMID:
27103740
20.

Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.

Linkins LA, Warkentin TE, Pai M, Shivakumar S, Manji RA, Wells PS, Wu C, Nazi I, Crowther MA.

J Thromb Haemost. 2016 Jun;14(6):1206-10. doi: 10.1111/jth.13330. Epub 2016 May 10.

21.

Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem.

Agzarian J, Hanna WC, Schneider L, Schieman C, Finley CJ, Peysakhovich Y, Schnurr T, Nguyen-Do D, Linkins LA, Douketis J, Crowther M, De Perrot M, Waddell TK, Shargall Y.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):992-9. doi: 10.1016/j.jtcvs.2015.11.038. Epub 2015 Nov 26.

22.

Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study.

Bates SM, Takach Lapner S, Douketis JD, Kearon C, Julian J, Parpia S, Schulman S, Weitz JI, Linkins LA, Crowther M, Lim W, Spencer FA, Lee AY, Gross PL, Ginsberg J.

J Thromb Haemost. 2016 Mar;14(3):504-9. doi: 10.1111/jth.13234. Epub 2016 Feb 5.

23.

Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab.

Al-Shamsi HO, Al Farsi A, Anjum M, Shen H, Zbuk K, Cook RJ, Linkins LA, Major P.

J Gastrointest Oncol. 2015 Jun;6(3):274-9. doi: 10.3978/j.issn.2078-6891.2015.025.

24.

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study.

Linkins LA, Bates SM, Lee AY, Heddle NM, Wang G, Warkentin TE.

Blood. 2015 Jul 30;126(5):597-603. doi: 10.1182/blood-2014-12-618165. Epub 2015 Apr 29.

PMID:
25926600
25.

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.

Schulman S, Zondag M, Linkins L, Pasca S, Cheung YW, de Sancho M, Gallus A, Lecumberri R, Molnar S, Ageno W, Le Gal G, Falanga A, Hulegårdh E, Ranta S, Kamphuisen P, Debourdeau P, Rigamonti V, Ortel TL, Lee A.

J Thromb Haemost. 2015 Jun;13(6):1010-8. doi: 10.1111/jth.12955. Epub 2015 May 9.

26.

Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages.

Warkentin TE, Safyan EL, Linkins LA.

N Engl J Med. 2015 Jan 29;372(5):492-4. doi: 10.1056/NEJMc1414161. No abstract available.

PMID:
25629757
27.

Heparin induced thrombocytopenia.

Linkins LA.

BMJ. 2015 Jan 8;350:g7566. doi: 10.1136/bmj.g7566. No abstract available.

PMID:
25569604
28.

Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.

Wu C, Alotaibi GS, Alsaleh K, Linkins LA, McMurtry MS.

Thromb Res. 2015 Feb;135(2):243-8. doi: 10.1016/j.thromres.2014.10.033. Epub 2014 Dec 2.

PMID:
25488466
29.

Rivaroxaban for treatment of HIT: a riveting first experience.

Linkins LA, Warkentin TE.

Thromb Res. 2015 Jan;135(1):1-2. doi: 10.1016/j.thromres.2014.10.019. Epub 2014 Nov 1. No abstract available.

PMID:
25466840
30.

Monitoring the anticoagulant effect after a massive rivaroxaban overdose.

Linkins LA, Moffat K.

J Thromb Haemost. 2014 Sep;12(9):1570-1. doi: 10.1111/jth.12669. Epub 2014 Aug 11.

31.

Venous thromboembolism in older adults: A community-based study.

Spencer FA, Gurwitz JH, Schulman S, Linkins LA, Crowther MA, Ginsberg JS, Lee AY, Saczynski JS, Anand S, Lessard D, Emery C, Huang W, Goldberg RJ.

Am J Med. 2014 Jun;127(6):530-7.e3. doi: 10.1016/j.amjmed.2014.02.011. Epub 2014 Feb 18.

PMID:
24561112
32.

Design of the rivaroxaban for heparin-induced thrombocytopenia study.

Linkins LA, Warkentin TE, Pai M, Shivakumar S, Manji RA, Wells PS, Crowther MA.

J Thromb Thrombolysis. 2014 Nov;38(4):485-92. doi: 10.1007/s11239-014-1064-7.

PMID:
24549975
33.

Response to Dr Junqueira.

Linkins LA, Dans AL, Moores CLK, Davidson BL, Schulman S, Crowther M.

Chest. 2013 Apr;143(4):1191. doi: 10.1378/chest.13-0035. No abstract available.

PMID:
23546509
34.

Bleeding risks associated with vitamin K antagonists.

Linkins LA.

Blood Rev. 2013 May;27(3):111-8. doi: 10.1016/j.blre.2013.02.004. Epub 2013 Mar 7. Review.

PMID:
23473948
35.

Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial.

Linkins LA, Bates SM, Lang E, Kahn SR, Douketis JD, Julian J, Parpia S, Gross P, Weitz JI, Spencer FA, Lee AY, O'Donnell MJ, Crowther MA, Chan HH, Lim W, Schulman S, Ginsberg JS, Kearon C.

Ann Intern Med. 2013 Jan 15;158(2):93-100. doi: 10.7326/0003-4819-158-2-201301150-00003.

PMID:
23318311
36.

Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M.

Chest. 2012 Feb;141(2 Suppl):e495S-e530S. doi: 10.1378/chest.11-2303. Review. Erratum in: Chest. 2015 Dec;148(6):1529.

37.

Heparin-induced thrombocytopenia: real-world issues.

Linkins LA, Warkentin TE.

Semin Thromb Hemost. 2011 Sep;37(6):653-63. doi: 10.1055/s-0031-1291375. Epub 2011 Nov 18.

PMID:
22102268
38.

New and emerging anticoagulant therapies for venous thromboembolism.

Linkins LA, Weitz JI.

Curr Treat Options Cardiovasc Med. 2010 Apr;12(2):142-55. doi: 10.1007/s11936-010-0067-8.

PMID:
20842552
39.

Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy.

Linkins L, O'Donnell M, Julian JA, Kearon C.

J Thromb Haemost. 2010 Oct;8(10):2201-7. doi: 10.1111/j.1538-7836.2010.04016.x. Review.

40.

Non-necrotizing heparin-induced skin lesions and the 4T's score.

Warkentin TE, Linkins LA.

J Thromb Haemost. 2010 Jul;8(7):1483-5. doi: 10.1111/j.1538-7836.2010.03880.x. Epub 2010 Apr 8. No abstract available.

41.

High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.

Kerr J, Linkins LA.

Thromb Haemost. 2010 Jan;103(1):123-8. doi: 10.1160/TH09-07-0438. Epub 2009 Oct 26.

PMID:
20062935
42.

Immunoassays are not created equal.

Warkentin TE, Linkins LA.

J Thromb Haemost. 2009 Aug;7(8):1256-9. doi: 10.1111/j.1538-7836.2009.03489.x. Epub 2009 Jun 30. Review. No abstract available.

43.

Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis.

Cook D, Sinuff T, Zytaruk N, Rabbat C, Lee A, O'Donnell M, Thabane L, Linkins L, Treleaven D, Patel R, Meade M, Crowther M, Marshall JC, Douketis J; DIRECT Investigators and Canadian Critical Care Trials Group.

J Crit Care. 2009 Jun;24(2):168-75. doi: 10.1016/j.jcrc.2009.01.010. Epub 2009 Mar 27.

PMID:
19327956
44.

Differences in clinical presentation of deep vein thrombosis in men and women.

Andreou ER, Koru-Sengul T, Linkins L, Bates SM, Ginsberg JS, Kearon C.

J Thromb Haemost. 2008 Oct;6(10):1713-9. doi: 10.1111/j.1538-7836.2008.03110.x. Epub 2008 Jul 28.

45.

Management of venous thromboembolism in patients with cancer: role of dalteparin.

Linkins LA.

Vasc Health Risk Manag. 2008;4(2):279-87. Review.

46.

The approach to heparin-induced thrombocytopenia.

Linkins LA, Warkentin TE.

Semin Respir Crit Care Med. 2008 Feb;29(1):66-74. doi: 10.1055/s-2008-1047564. Review.

PMID:
18302088
47.

Beyond heparin and warfarin: the new generation of anticoagulants.

Weitz JI, Linkins LA.

Expert Opin Investig Drugs. 2007 Mar;16(3):271-82. Review.

PMID:
17302522
48.

OASIS-6: should patients with acute ST-segment elevation myocardial infarction be treated with fondaparinux?

Linkins LA, Weitz JI.

Nat Clin Pract Cardiovasc Med. 2006 Sep;3(9):478-9. No abstract available.

PMID:
16932763
49.

An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial.

Kearon C, Ginsberg JS, Douketis J, Turpie AG, Bates SM, Lee AY, Crowther MA, Weitz JI, Brill-Edwards P, Wells P, Anderson DR, Kovacs MJ, Linkins LA, Julian JA, Bonilla LR, Gent M; Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) Group.

Ann Intern Med. 2006 Jun 6;144(11):812-21.

PMID:
16754923
50.

Supplemental Content

Loading ...
Support Center